Reversion to normoglycemia with tirzepatide vs semaglutide in participants with obesity and prediabetes: a post hoc analysis of SURMOUNT-5. Academic Article uri icon

Overview

publication date

  • April 20, 2026

Identity

Digital Object Identifier (DOI)

  • 10.1007/s40618-026-02895-3

PubMed ID

  • 42002673